Literature DB >> 9565088

Apoptosis, graft rejection, and transplantation tolerance.

D Kabelitz1.   

Abstract

Transplantation tolerance can be achieved through several mechanisms, including the action of suppressor cells, the induction of anergy, or the deletion of graft-reactive donor T cells. In this article, the possible involvement of programmed cell death (apoptosis) in allograft rejection and transplantation tolerance is discussed. The recent characterization of members of the tumor necrosis factor-alpha gene family has identified ligands (Fas ligand and TRAIL) and corresponding death receptors (DR). In rejected organ transplants, apoptotic cells are frequently encountered. Conversely, high-level expression of Fas ligand on the allograft correlates with graft acceptance in some models of organ transplantation. Furthermore, some of the immunosuppressive drugs currently in clinical use might exert their activity at least in part through effects on apoptotic pathways. From the available data, it can be inferred that apoptosis contributes to the outcome after organ transplantation, being involved both in graft rejection and in transplantation tolerance.

Entities:  

Mesh:

Year:  1998        PMID: 9565088     DOI: 10.1097/00007890-199804150-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients.

Authors:  L A Chau; S Rohekar; J-J Wang; D Lian; S Chakrabarti; L Zhang; R Zhong; J Madrenas
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Time-lapse imaging of cell death in cell culture and whole living organisms using turn-on deep-red fluorescent probes.

Authors:  Tia S Jarvis; Felicia M Roland; Kyle M Dubiak; Paul W Huber; Bradley D Smith
Journal:  J Mater Chem B       Date:  2018-07-10       Impact factor: 6.331

3.  Human allograft acceptance is associated with immune regulation.

Authors:  A M VanBuskirk; W J Burlingham; E Jankowska-Gan; T Chin; S Kusaka; F Geissler; R P Pelletier; C G Orosz
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Authors:  F Porcheray; J W Fraser; B Gao; A McColl; J DeVito; I Dargon; Y Helou; W Wong; T C Girouard; S L Saidman; R B Colvin; A Palmisano; U Maggiore; A Vaglio; R N Smith; E Zorn
Journal:  Am J Transplant       Date:  2013-08-06       Impact factor: 8.086

5.  Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts.

Authors:  Kanji Minamoto; David J Pinsky
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.